Undiagnosed, untreated blood disorders in women and young girls have medical consequences and unique issues at every life stage, creating the need for a foundation dedicated to education and awareness.
We work to achieve this goal by raising awareness and educating the key healthcare providers for each particular life stage and translating and disseminating provider information and research.
Ming Y. Lim, MBBChir, MSCR received our Research Fellowship Award for a study on von Willebrand disease.
Join ASH, ACOG, AMCHP, & SCDAA for a virtual Congressional Briefing on reproductive health care for women with SCD on Thurs., Oct. 28, from 2-3 pm ET.
Join us on Wednesday, October 13, to honor World Thrombosis Day in partnership with ISTH. World Thrombosis Day (www.worldthrombosisday.org) is a global day of advocacy designed to draw attention to the 1 in 4 people worldwide dying from conditions caused by thrombosis.
The CDC needs your feedback as it seeks public comment on CDC’s contraception guidance, U.S. Medical Eligibility Criteria for Contraceptive Use, 2016 (US MEC) and U.S. Selected Practice Recommendations for Contraceptive Use, 2016 (US SPR).
Our congratulations to Dr. Julia Coleman, the 2018 FWGBD Promoting XXcellence in Women's Health award winner, who recently won the American College of Surgeons Committee on Trauma's National Resident Paper Competition for her work on whole blood thrombin generation.
Our congratulations to FWGBD members, led by Dr. Lydia Pecker and Dr. Deva Sharma, who recently authored a journal article on knowledge gaps in reproductive and sexual health in women and girls with sickle cell disease.
Our congratulations to WGSCD LAN member Dr. Andrea Roe and long-time FWGBD supporter Dr. Kim Smith-Whitley, who have recently published an insightful journal article on contraceptive use and preferences in females with sickle cell disease.
Please plan to join NHF for its State of the Science Research Summit from Sept. 12-15, 2021.
Cure HHT, in conjunction with the CDC, will be offering a free webinar on "Hereditary Hemorrhagic Telangiectasia in 2021: Diagnosis and Advances in Treatment" on Thursday, August 19, 2021, from 2:00-3:00 PM EDT.
